Systemic Therapy For Advanced Hepatocellular Carcinoma Guideline

Summary

An interview with Dr. John D. Gordan from the University of California, San Francisco, and Dr. Michal G. Rose from Yale Panelists Ghassan K. Abou-Alfa, MD; Amit G. Singal, MD; and Richard Finn, MD, outline patient and disease factors to consider ... Dr. John Gordan discusses the newest evidence-based Arndt Vogel, MD, Hannover Medical School, Hanover, Germany, explores future Join the Oncology Brothers, Drs. Rahul and Rohit Gosain, in this engaging podcast episode as they delve into the Liver cancers are on the rise in the Western part of the world. Johns Hopkins has a multidisciplinary liver Jeroen Dekervel, MD, PhD, KU Leuven, Leuven, Belgium, comments on factors affecting individualized first-line Advanced hepatocellular carcinoma Practice-Changing Updates in Different Settings of Case Scenarios to Integrate Recent Progress There has been remarkable progress in the ... Cancer Research, elaborates on the latest in Lorenza Rimassa, MD, Hunimed University, Milan, Italy, discusses the Course Director, Riccardo Lencioni, MD, FSIR, EBIR, discusses